Thomas Cid Ming Chin, MD
Dermatology Physician · New York, NY
Thomas Cid Ming Chin, MD is a dermatology physician with a practice address in New York, New York, and NPI 1790840361, issued on Dec 26, 2006. Check the license (New York 129269, as entered in NPPES) on the NYS Education Department, Office of the Professions; the Medicare figures below come from public CMS files.
- Name
- Thomas Cid Ming Chin
- Credential
- MD
- Primary taxonomy
- Dermatology Physician 207N00000X
- License number
- 129269 NY
Self-reported in NPPES; status is on the state search - Practice location
- 8 Chatham Square, New York, NY 10038
- Phone
- (212) 233-2033
- Enumerated
- Dec 26, 2006
- Record last updated
- Jan 19, 2010 (not updated in 16 years: call before relying on the address or phone)
- Fax
- (212) 966-7265
- Medicare enrollment
- Enrolled (PECOS I20110118001134); accepts Medicare assignment
- Medical or professional school
- Albert Einstein College Of Medicine Of Yeshiva University, 1975
- Entity
- Type 1 · individual
8 nearest dermatology physician records → All 1,211 in New York → Look up another NPI →
Also registered at 8 Chatham Square
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Pearl Tam, MDAllergy & Immunology Physician1649331471
Verify Thomas Cid Ming Chin in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersNYS Education Department, Office of the Professions
Search for license 129269Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
40% fewer Medicare Part D claims than the average dermatology physician in 2024
476 Medicare Part D claims for 145 beneficiaries, against an average of 797 among the 12,802 providers of this specialty who prescribed in Part D.
Most prescribed
- Levocetirizine Dihydrochloride167 claims
- Mometasone Furoate33 claims
- Tacrolimus28 claims
- Betamethasone Diprop Augmented25 claims
- Famotidine20 claims
- Fluocinolone Acetonide20 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $1,103.42
17 payments; by number, the most common kind was food and beverage; the largest payer was AstraZeneca Pharmaceuticals LP. The 10,250 providers of this specialty with any payment received $8,544.61 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Thomas Cid Ming Chin among 1,211 dermatology physician records in New York
Thomas Cid Ming Chin, MD is one of 1,211 dermatology physician records with a practice address in New York. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 12% of them.
- NPI issued2006 · 12% of these records are older, 54% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileYes · 73% of these records are
- Graduated1975 · median 2004 among the 880 with a school on file
- Record last updated2010 · 61% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207N00000X and a New York practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Dermatology Physician providers in New York
There are 1,211 dermatology physician records in New York.
All 1,211 in New York → Every provider in New York → Dermatology Physician nationwide →
The 8 dermatology physician records with the nearest ZIP codes
- Andrew Avarbock, M.D., PH.D.New York, NY 100381669649968
- Lyubov Avshalumova, D.O.New York, NY 100381407157928
- Robert Buka, MDNew York, NY 100381427029180
- Barry Goldman, M.D.New York, NY 100381831139856
- Michael LorNew York, NY 100381285211060
- Helen Radoszycki, M.D.New York, NY 100381073512307
- Gilberto Alvarez Del Manzano, MDNew York, NY 100361750304663
- George Jordan, M.D.New York, NY 100351346329141
Common questions
What is Thomas Cid Ming Chin, MD's NPI number?
Thomas Cid Ming Chin, MD's National Provider Identifier (NPI) is 1790840361, issued on Dec 26, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Thomas Cid Ming Chin, MD located?
The NPPES record lists a practice address at 8 Chatham Square, New York, NY, 10038. Phone: (212) 233-2033. Providers update this record themselves, so call before visiting.
How can I verify Thomas Cid Ming Chin, MD's license?
NPPES lists New York license number 129269, as entered by the provider. Search the NYS Education Department, Office of the Professions at https://www.op.nysed.gov/services/verifications/online-verification-searches. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Thomas Cid Ming Chin, MD prescribe under Medicare Part D?
In 2024, Thomas Cid Ming Chin, MD had 476 Medicare Part D claims for 145 beneficiaries; the average among dermatology physician prescribers was 797. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.